Synergistic effects of Alpelisib (PI3K inhibitor) and Ribociclib (CDK4/6 inhibitor) combination in preclinical colorectal cancer models

Activity: Examination typesPhD external examination

Description

PhD thesis
Period23 Jan 2023
ExamineeRasia Aslam
Examination held at
  • RCSI University of Medicine and Health Sciences, Dublin
Degree of RecognitionInternational